Processing, signaling, and physiological function of chemerin

IUBMB Life

Volumn 66, Issue 1, 2014, Pages 19-26

  Mattern, Andreas ^a   Zellmann, Tristan ^a   Beck Sickinger, Annette G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

chemerin; CMKLR1; inflammation; obesity; psoriasis; skin

Indexed keywords

CHEMERIN; CMKLR1; INFLAMMATION; OBESITY; PSORIASIS; SKIN;

CELL PHYSIOLOGICAL PHENOMENA; CHEMOKINES; HUMANS; INFLAMMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84893765411     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1242     Document Type: Review

References (55)

1. Trayhurn, P., and, Beattie, J. H., (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60, 329-339.
2. Rosen, E. D., and, Spiegelman, B. M., (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853.
3. Nedvidkova, J., Smitka, K., Kopsky, V., and, Hainer, V., (2005) Adiponectin, an adipocyte-derived protein. Physiol Res 54, 133-140.
4. Hotamisligil, G. S., (1999) The role of TNF alpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245, 621-625.
5. Rotter, V., Nagaev, I., and, Smith, U., (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278, 45777-45784.
6. Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 4687-4694.
7. Nagpal, S., Patel, S., Jacobe, H., DiSepio, D., Ghosn, C., et al. (1997) Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109, 91-95.
8. Wittamer, V., Franssen, J. D., Vulcano, M., Mirjolet, J. F., Le Poul, E., et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198, 977-985.
9. Barnea, G., Strapps, W., Herrada, G., Berman, Y., Ong, J., et al. (2008) The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 105, 64-69.
10. Zabel, B. A., Nakae, S., Zuniga, L., Kim, J. Y., Ohyama, T., et al. (2008) Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J. Exp. Med. 205, 2207-2220.
11. Goralski, K. B., McCarthy, T. C., Hanniman, E. A., Zabel, B. A., Butcher, E. C., et al. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282, 28175-28188.
12. Muruganandan, S., Roman, A. A., and, Sinal, C. J., (2010) Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J. Bone Miner. Res. 25, 222-234.
13. Kaur, J., Adya, R., Tan, B. K., Chen, J., and, Randeva, H. S., (2010) Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem. Biophys. Res. Commun. 391, 1762-1768.
14. Schultz, S., Saalbach, A., Heiker, J. T., Meier, R., Zellmann, T., et al. (2013) Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement. Biochem. J. 452, 271-280.
15. Parolini, S., Santoro, A., Marcenaro, E., Luini, W., Massardi, L., et al. (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109, 3625-3632.
16. Meder, W., Wendland, M., Busmann, A., Kutzleb, C., Spodsberg, N., et al. (2003) Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett. 555, 495-499.
17. Du, X. Y., Zabel, B. A., Myles, T., Allen, S. J., Handel, T. M., et al. (2009) Regulation of chemerin bioactivity by plasma carboxypeptidase n, carboxypeptidase b (activated thrombin-activable fibrinolysis inhibitor), and platelets. J. Biol. Chem. 284, 751-758.
18. Guillabert, A., Wittamer, V., Bondue, B., Godot, V., Imbault, V., et al. (2008) Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J. Leukoc. Biol. 84, 1530-1539.
19. Yamaguchi, Y., Du, X. Y., Zhao, L., Morser, J., and, Leung, L. L. K., (2011) Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma. J. Biol. Chem. 286, 39510-39519.
20. Zhao, L., Yamaguchi, Y., Sharif, S., Du, X. Y., Song, J. J., et al. (2011) Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma. J. Biol. Chem. 286, 39520-39527.
21. Zabel, B. A., Allen, S. J., Kulig, P., Allen, J. A., Cichy, J., et al. (2005) Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J. Biol. Chem. 280, 34661-34666.
22. Wittamer, V., Gregoire, F., Robberecht, P., Vassart, G., Communi, D., et al. (2004) The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279, 9956-9962.
23. Gantz, I., Konda, Y., Yang, Y. K., Miller, D. E., Dierick, H. A., et al. (1996) Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. Cytogenet. Cell Genet. 74, 286-290.
24. Samson, M., Edinger, A. L., Stordeur, P., Rucker, J., Verhasselt, V., et al. (1998) ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur. J. Immunol. 28, 1689-1700.
25. Vermi, W., Riboldi, E., Wittamer, V., Gentili, F., Luini, W., et al. (2005) Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201, 509-515.
26. Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., et al. (2008) Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848-855.
27. Haack, K. K. V., and, McCarty, N. A., (2011) Functional consequences of GPCR heterodimerization: GPCRs as allosteric modulators. Pharmaceuticals 4, 509-523.
28. de Poorter, C., Baertsoen, K., Lannoy, V., Parmentier, M., and, Springael, J. Y., (2013) Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7. PLoS One 8, e58075.
29. Sohy, D., Yano, H., de Nadai, P., Urizar, E., Guillabert, A., et al. (2009) Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of "Selective" Antagonists. J. Biol. Chem. 284, 31270-31279.
30. Joost, P., and, Methner, A., (2002) Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol. 3.
31. Rovati, G. E., Capra, V., and, Neubig, R. R., (2007) The highly conserved DRY motif of class A G protein-coupled receptors: Beyond the ground state. Mol. Pharmacol. 71, 959-964.
32. Marchese, A., Docherty, J. M., Nguyen, T., Heiber, M., Cheng, R., et al. (1994) Cloning of human genes encoding novel G-protein-coupled receptors. Genomics 23, 609-618.
33. Shimizu, N., Soda, Y., Kanbe, K., Liu, H. Y., Jinno, A., et al. (1999) An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells. J. Virol. 73, 5231-5239.
34. Edinger, A. L., Hoffman, T. L., Sharron, M., Lee, B., O'Dowd, B., et al. (1998) Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 249, 367-378.
35. Fan, P., Kyaw, H., Su, K., Zeng, Z. Z., Augustus, M., et al. (1998) Cloning and characterization of a novel human chemokine receptor. Biochem. Biophys. Res. Commun. 243, 264-268.
36. Migeotte, I., Franssen, J. D., Goriely, S., Willems, F., and, Parmentier, M., (2002) Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. Eur. J. Immunol. 32, 494-501.
37. Monnier, J., Lewen, S., O'Hara, E., Huang, K., Tu, H., et al. (2012) Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J. Immunol. 189, 956-967.
38. Damaj, B. B., McColl, S. R., Neote, K., Na, S. Q., Ogborn, K. T., et al. (1996) Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J. 10, 1426-1434.
39. Yoshimura, T., and, Oppenheim, J. J., (2011) Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual properties. Exp. Cell Res. 317, 674-684.
40. Becker, M., Rabe, K., Lebherz, C., Zugwurst, J., Goke, B., et al. (2010) Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 59, 2898-2903.
41. Landgraf, K., Friebe, D., Ullrich, T., Kratzsch, J., Dittrich, K., et al. (2012) Chemerin as a mediator between obesity and vascular inflammation in children. J. Clin. Endocrinol. Metab. 97, E556-564.
42. Bozaoglu, K., Segal, D., Shields, K. A., Cummings, N., Curran, J. E., et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J. Clin. Endocrinol. Metab. 94, 3085-3088.
43. Chakaroun, R., Raschpichler, M., Kloting, N., Oberbach, A., Flehmig, G., et al. (2012) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 61, 706-714.
44. Takahashi, M., Takahashi, Y., Takahashi, K., Zolotaryov, F. N., Hong, K. S., et al. (2008) Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582, 573-578.
45. Ernst, M. C., Haidl, I. D., Zuniga, L. A., Dranse, H. J., Rourke, J. L., et al. (2012) Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 153, 672-682.
46. Rouger, L., Denis, R., Luangsay, S., and, Parmentier, M., (2013) ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation. J Endocrinol 219, 279-289.
47. Garces, M. F., Sanchez, E., Acosta, B. J., Angel, E., Ruiz, A. I., et al. (2012) Expression and regulation of chemerin during rat pregnancy. Placenta 33, 373-378.
48. Ritterath, C., Rad, N. T., Siegmund, T., Heinze, T., Siebert, G., et al. (2010) Adiponectin during pregnancy: correlation with fat metabolism, but not with carbohydrate metabolism. Arch. Gynecol. Obstet. 281, 91-96.
49. Ha, Y. J., Kang, E. J., Song, J. S., Park, Y. B., Lee, S. K., et al. Plasma chemerin levels in rheumatoid arthritis are correlated with disease activity rather than obesity. Joint Bone Spine, in press.
50. Herenius, M. M., Oliveira, A. S., Wijbrandts, C. A., Gerlag, D. M., Tak, P. P., et al. (2013) Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation. PLoS One 8, e57802.
51. Cash, J. L., Hart, R., Russ, A., Dixon, J. P. C., Colledge, W. H., et al. (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767-775.
52. Bondue, B., De Henau, O., Luangsay, S., Devosse, T., de Nadai, P., et al. (2012) The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo. PLoS One 7, e40043.
53. Lora, V., Bonaguri, C., Gisondi, P., Sandei, F., Battistelli, L., et al. (2013) Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. Immunol. Res. 56, 382-389.
54. Banas, M., Zabieglo, K., Kasetty, G., Kapinska-Mrowiecka, M., Borowczyk, J., et al. (2013) Chemerin is an antimicrobial agent in human epidermis. PLoS One 8, e58709.
55. Pachynski, R. K., Zabel, B. A., Kohrt, H. E., Tejeda, N. M., Monnier, J., et al. (2012) The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. J. Exp. Med. 209, 1427-1435.